These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8155772)

  • 1. Immunotherapy for cancer by direct gene transfer into tumors.
    Nabel GJ; Chang AE; Nabel EG; Plautz GE; Ensminger W; Fox BA; Felgner P; Shu S; Cho K
    Hum Gene Ther; 1994 Jan; 5(1):57-77. PubMed ID: 8155772
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7.
    Rubin J; Galanis E; Pitot HC; Richardson RL; Burch PA; Charboneau JW; Reading CC; Lewis BD; Stahl S; Akporiaye ET; Harris DT
    Gene Ther; 1997 May; 4(5):419-25. PubMed ID: 9274718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to the points to consider for immunotherapy of malignancy by in vivo gene transfer into tumors.
    Hum Gene Ther; 1992 Dec; 3(6):705-11. PubMed ID: 1482710
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunotherapy of malignancy by in vivo gene transfer into tumors.
    Hum Gene Ther; 1992 Aug; 3(4):399-410. PubMed ID: 1525212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer.
    Rubin J; Charboneau JW; Reading C; Kovach JS
    Hum Gene Ther; 1994 Nov; 5(11):1385-99. PubMed ID: 7893809
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase I study of immunotherapy of malignant melanoma by direct gene transfer.
    Hersh EM; Akporiaye E; Harris D; Stopeck AT; Unger EC; Warneke JA; Kradjian SA
    Hum Gene Ther; 1994 Nov; 5(11):1371-84. PubMed ID: 7893808
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase I study of immunotherapy of metastatic renal cell carcinoma by direct gene transfer into metastatic lesions.
    Vogelzang NJ; Lestingi TM; Sudakoff G; Kradjian SA
    Hum Gene Ther; 1994 Nov; 5(11):1357-70. PubMed ID: 7893807
    [No Abstract]   [Full Text] [Related]  

  • 8. Major histocompatibility gene therapy: the importance of haplotype and beta 2-microglobulin.
    Salamone FN; Gleich LL; Li YQ; Stambrook PJ
    Laryngoscope; 2004 Apr; 114(4):612-5. PubMed ID: 15064612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient recovery of HLA class I expression in human tumor cells after beta2-microglobulin gene transfer using adenoviral vector: implications for cancer immunotherapy.
    del Campo AB; Aptsiauri N; Méndez R; Zinchenko S; Vales A; Paschen A; Ward S; Ruiz-Cabello F; González-Aseguinolaza G; Garrido F
    Scand J Immunol; 2009 Aug; 70(2):125-35. PubMed ID: 19630918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer gene therapy using plasmid DNA: safety evaluation in rodents and non-human primates.
    Parker SE; Vahlsing HL; Serfilippi LM; Franklin CL; Doh SG; Gromkowski SH; Lew D; Manthorpe M; Norman J
    Hum Gene Ther; 1995 May; 6(5):575-90. PubMed ID: 7578395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical pharmacokinetics, manufacturing, and safety studies supporting a multicenter cancer gene therapy trial.
    Norman JA; Parker S; Lew D; Manthorpe M; Marquet M
    Hum Gene Ther; 1995 May; 6(5):549-50. PubMed ID: 7578391
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of HLA-B7/beta-2 microglobulin plasmid DNA/lipid complex (Allovectin-7) in patients with metastatic melanoma.
    Bergen M; Chen R; Gonzalez R
    Expert Opin Biol Ther; 2003 Apr; 3(2):377-84. PubMed ID: 12662150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I study of direct intralesional gene transfer of HLA-B7 into metastatic renal carcinoma lesions.
    Rini BI; Selk LM; Vogelzang NJ
    Clin Cancer Res; 1999 Oct; 5(10):2766-72. PubMed ID: 10537340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer gene therapy using plasmid DNA: purification of DNA for human clinical trials.
    Horn NA; Meek JA; Budahazi G; Marquet M
    Hum Gene Ther; 1995 May; 6(5):565-73. PubMed ID: 7578394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the HLA-Cw3-specific cytotoxic T lymphocyte response of HLA-B7 X human beta 2m double transgenic mice.
    Barra C; Pérarnau B; Gerlinger P; Lemeur M; Gillet A; Gibier P; Lemonnier FA
    J Immunol; 1989 Nov; 143(10):3117-24. PubMed ID: 2478616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct gene transfer for treatment of human cancer.
    Nabel GJ; Yang ZY; Nabel EG; Bishop K; Marquet M; Felgner PL; Gordon D; Chang AE
    Ann N Y Acad Sci; 1995 Nov; 772():227-31. PubMed ID: 8546397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Velimogene aliplasmid.
    Soares HP; Lutzky J
    Expert Opin Biol Ther; 2010 May; 10(5):841-51. PubMed ID: 20367461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexpression of the human HLA-A2 or HLA-B7 heavy chain gene and human beta 2-microglobulin gene in L cells.
    Bernabeu C; Maziarz R; Spits H; de Vries J; Burakoff SJ; Terhorst C
    J Immunol; 1984 Dec; 133(6):3188-94. PubMed ID: 6436376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abrogation of H-2-restricted CTL responses and efficient recognition of HLA-A3 molecules in DBA/2 HLA/A24 responder mice.
    Barra C; Gournier H; Garcia Z; Marche PN; Jouvin-Marche E; Briand P; Fillipi P; Lemonnier FA
    J Immunol; 1993 May; 150(9):3681-9. PubMed ID: 7682582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue distribution of the cytofectin component of a plasmid-DNA/cationic lipid complex following intravenous administration in mice.
    Parker SE; Ducharme S; Norman J; Wheeler CJ
    Hum Gene Ther; 1997 Mar; 8(4):393-401. PubMed ID: 9054514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.